# Ocugen, Inc.: Form D filings

Ocugen, Inc., a biotechnology company in Malvern, PA, filed 7 Form D notices with the SEC between 2011 and 2020. The latest, on May 7, 2020, reports $395 sold of a $395 offering to 1 investor.

Find out what Ocugen, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Ocugen%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Ocugen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Focugen-inc-1372299)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Ocugen%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Ocugen%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Focugen-inc-1372299)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5 GREAT VALLEY PARKWAY, SUITE 160, Malvern, PA, 19355
- Phone: (484) 328-4698
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1372299

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 7, 2020 | New notice | $395 | $395 | $0 | 1 | Apr 22, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000119248220000313/0001192482-20-000313-index.htm) |
| May 7, 2020 | New notice | $14,283,724 | $14,283,724 | $0 | 6 | Apr 22, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000119248220000312/0001192482-20-000312-index.htm) |
| Oct 12, 2016 | New notice | $30,000,001 | $30,000,001 | $0 | 20 | Sep 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000167140016000002/0001671400-16-000002-index.htm) |
| Jan 6, 2014 | New notice | $20,647,968 | $10,323,988 | $10,323,980 | 17 | Dec 18, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000137229914000001/0001372299-14-000001-index.htm) |
| Nov 26, 2012 | Amendment | $58,286,647 | $37,638,679 | $20,647,968 | 13 | Jul 20, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000137229912000003/0001372299-12-000003-index.htm) |
| Jul 27, 2012 | New notice | $58,036,647 | $37,488,679 | $20,547,968 | 12 | Jul 20, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000137229912000002/0001372299-12-000002-index.htm) |
| May 26, 2011 | New notice | Indefinite | $34,300,000 | Indefinite | 15 | May 13, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1372299/000119248211000130/0001192482-11-000130-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Manish B Potti | Director |  |
| Sanjay B Subramanian | Executive Officer |  |
| Suha B Taspolatoglu | Director |  |
| Shankar Musunuri | Executive Officer, Director |  |
| Daniel B Jorgensen | Executive Officer |  |
| Prabhavathi B Fernandes | Director |  |
| Kristen B Castillo | Director |  |
| Ramesh Kumar | Director |  |
| Kelly B Beck | Executive Officer |  |
| Uday B Kompella | Director |  |
| Rasappa B Arumugham | Executive Officer |  |
| Vijay B Tammara | Executive Officer |  |
| Junge Zhang | Director |  |

## Other biotechnology companies in Pennsylvania that filed recently

- [Traws Pharma, Inc.](https://specstream.ai/data/form-d/company/traws-pharma-inc-1130598) offering · Nov 5, 2026
- [BioLattice Ophthalmics, Inc,](https://specstream.ai/data/form-d/company/biolattice-ophthalmics-inc-2125596) $1.8 million · Oct 28, 2026
- [Myris Therapeutics, Inc.](https://specstream.ai/data/form-d/company/myris-therapeutics-inc-1924725) $500,000 · Oct 14, 2026
- [Praeventix, Inc.](https://specstream.ai/data/form-d/company/praeventix-inc-1952974) $5.6 million · Sep 10, 2026
- [Plowshare Therapies LLC](https://specstream.ai/data/form-d/company/plowshare-therapies-llc-2152111) $6.7 million · Aug 31, 2026
- [Noveome Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/noveome-biotherapeutics-inc-1478304) $6.8 million · Aug 27, 2026
- [AlloTRx Bio Inc.](https://specstream.ai/data/form-d/company/allotrx-bio-inc-2151424) $500,000 · Aug 24, 2026
- [Aposture Surgical Corp](https://specstream.ai/data/form-d/company/aposture-surgical-corp-2148299) $87,000 · Aug 13, 2026
- [Merlin Biotech, Inc.](https://specstream.ai/data/form-d/company/merlin-biotech-inc-2149714) $50,000 · Aug 11, 2026

[Every Form D from the week of May 4, 2020](https://specstream.ai/data/form-d/week/2020-05-04) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Ocugen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).